AbbVie boss mulls hostile move on Shire

Comment on this story

London - US drugmaker AbbVie declined to rule out a hostile bid for Shire on Wednesday but said it was pushing hard for the London-listed drugmaker to engage in talks, after its $46 billion takeover approach was rejected.

Questioned by analysts if he might make a hostile bid, chief executive Richard Gonzalez said on conference call: “We're not willing to restrict our legal options here.”

He declined to comment on what approach AbbVie might take if it went down a hostile path.

Gonzalez stressed he wanted to engage with Shire's management to better understand its upbeat drug sales forecasts, adding he also planned to meet with Shire shareholders. - Reuters

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines